Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mid-luteal GnRH Agonist Bolus in IVF/ICSI
NCT03039049Phase 3Completed
- Sponsor
- CHU Ibn Rochd
- Start
- Mar 2014
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triptorelin in infertility (2 arms), sponsored by CHU Ibn Rochd. Primary endpoint: Implantation rate. Started Mar 2014; status: completed.
02
Drugs
triptorelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03039049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039049.